TG Therapeutics | TGTX - Aktuelle Verpflichtungen

Aktienkurs
33.73
Täglich Wechseln
-0.90 -2.60%
Monatlich
20.25%
Jährlich
-8.12%
Q2 Prognose
32.81




Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 43.29B 3.9B 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Amgen USD 25.49B 3.7B 2025-12
Ardelyx USD 88.6M 5.22M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Biogen USD 3.35B 59.4M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Curis USD 14.08M 5.3M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novavax USD 459.95M 30.08M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Verastem USD 72.27M 12.56M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12